KTTA (Pasithea) Tingkat bathi reged

The gross profit margin chart on GURU.Markets reflects the strategy of Pasithea Therapeutics (KTTA) to develop depression therapies, where patents and grants ensure capital inflows. The latest value is recorded as 0.00, which is critical when scaling a pipeline that requires continuous laboratory investment. Integrating its own ketamine clinics with scientific research allows Pasithea Therapeutics (KTTA) to rapidly implement innovations in neuromedicine.
Rincian analitis lan laporan data perusahaan Pasithea Therapeutics Corp. (KTTA)

By outsourcing production and clinical trials, Pasithea Therapeutics (KTTA) minimizes capital expenditures, shifting operational risks to counterparties. This metric is calculated as the ratio of the difference between revenue and direct cost of goods sold to total sales, measuring the efficiency of base cost management. An analysis of sales margins allows for an assessment of the business's margin of safety and the accuracy of the asset's intrinsic value valuation.